How it works

Precautionary recapitalisation allows a Member State to inject own funds into a bank, or otherwise support its capital position, without that support meaning the bank is deemed to be failing or likely to fail. It is one of the narrow exceptions in the framework: normally, extraordinary public financial support is itself an indicator of non-viability, but precautionary measures are carved out where strict conditions are met.

The measure is confined to solvent institutions. It is intended to remedy a capital shortfall identified in an adverse scenario of a stress test, asset quality review or equivalent exercise conducted by the competent authority, the EBA or the ESRB. The support must be precautionary and temporary, proportionate to remedy the consequences of a serious disturbance in the economy, and it must not be used to offset losses that the institution has incurred or is likely to incur in the near future.

The injection is priced on market terms and requires prior approval under the Union state aid framework. Because the bank is solvent, the measure does not by itself place the institution into resolution; if the conditions cannot be met, the bank is instead assessed against the ordinary resolution conditions.

The concept is set out in the Bank Recovery and Resolution Directive as an exception to the failing-or-likely-to-fail assessment. Article 32(4)(d)(iii) of the BRRD lists precautionary recapitalisation among the forms of extraordinary public financial support that do not trigger a determination that the institution is failing or likely to fail, subject to the conditions described above. The parallel resolution conditions and the public interest assessment sit in Article 32 of the BRRD and, for banks in the Banking Union, Article 18 of the SRMR.

The measure interacts with the state aid regime: because it involves public funds, it must be cleared by the European Commission, and burden-sharing expectations under the state aid banking communications generally apply. It is distinct from the government financial stabilisation tools, which are last-resort instruments used within resolution itself.

Practical relevance

For banks, precautionary recapitalisation offers a route to address a stress-test shortfall without the value destruction and stigma of entering resolution, but only where the institution is genuinely solvent and the shortfall is forward-looking rather than a realised loss. The distinction between an anticipated shortfall under an adverse scenario and losses already incurred is central and often contested.

For investors, the measure matters because it defines a boundary: solvent banks receiving precautionary support are not in resolution, so instruments are not written down or converted under the resolution regime, although state aid burden-sharing can still require contributions from shareholders and subordinated creditors. Analysts watch stress-test outcomes closely because a shortfall can crystallise the question of whether an institution qualifies for precautionary support or must instead be resolved.

The tool has been used sparingly and remains one of the more debated features of the framework, precisely because it sits at the frontier between supervision and resolution.